Jack W. Singer, EVP, Chief Scientific Officer at CTI BIOPHARMA CORP (CTIC), sold 29,200 shares at $0.61 ($19K) on 2016-02-26, disclosed to the SEC on 2016-02-26.
Open-market sale of $19k CTIC by EVP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.61 | 100 | $62 | 0.3% |
| 2 | $0.62 | 300 | $185 | 1.0% |
| 3 | $0.62 | 510 | $316 | 1.7% |
| 4 | $0.62 | 100 | $62 | 0.3% |
| 5 | $0.62 | 200 | $124 | 0.7% |
| 6 | $0.62 | 300 |
| $186 |
| 1.0% |
| 7 | $0.62 | 510 | $317 | 1.7% |
| 8 | $0.62 | 100 | $62 | 0.3% |
| 9 | $0.62 | 200 | $125 | 0.7% |
| 10 | $0.63 | 200 | $125 | 0.7% |
| 11 | $0.63 | 3,990 | $3K | 13.6% |
| 12 | $0.63 | 300 | $189 | 1.0% |
| 13 | $0.63 | 600 | $378 | 2.0% |
| 14 | $0.63 | 100 | $63 | 0.3% |
| 15 | $0.63 | 200 | $126 | 0.7% |
| 16 | $0.63 | 100 | $63 | 0.3% |
| 17 | $0.63 | 600 | $380 | 2.0% |
| 18 | $0.63 | 3,990 | $3K | 13.6% |
| 19 | $0.64 | 600 | $381 | 2.1% |
| 20 | $0.64 | 1,130 | $719 | 3.9% |
| 21 | $0.64 | 2,600 | $2K | 8.9% |
| 22 | $0.64 | 3,270 | $2K | 11.3% |
| 23 | $0.64 | 200 | $128 | 0.7% |
| 24 | $0.64 | 3,270 | $2K | 11.3% |
| 25 | $0.64 | 200 | $128 | 0.7% |
| 26 | $0.64 | 500 | $320 | 1.7% |
| 27 | $0.64 | 100 | $64 | 0.3% |
| 28 | $0.64 | 600 | $384 | 2.1% |
| 29 | $0.64 | 1,130 | $723 | 3.9% |
| 30 | $0.64 | 2,600 | $2K | 9.0% |
| 31 | $0.64 | 100 | $64 | 0.3% |
| 32 | $0.64 | 500 | $322 | 1.7% |
| Total | $0.63 avg | 29,200 | $19K | 100% |
| Filing → |
| CTIC | SELL | 2015-11-30 | $18K | — | Filing → |
| CTIC | SELL | 2015-10-23 | $24K | — | Filing → |
| CTIC | SELL | 2015-10-01 | $142K | — | Filing → |